Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

November 14, 2018 Leave a comment 1,016 Views

Evox Therapeutics, a leading exosome therapeutics company, a leading exosome therapeutics company, today announces that it has secured £655,000 in funding from Duchenne UK. The grant will be invested to support exploration of the Company’s exosome-based therapeutic platform to deliver ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Duchenne UK

Evox Therapeutics wins funding from Duchenne UK to explore exosome-mediated delivery of dystrophin

Functional single-cell profiling identifies that exosomes are associated with increased immune cell infiltration in non-metastatic breast cancer

Liquid biopsy-based exo-oncomiRNAs can predict prostate cancer aggressiveness

The body’s own signalling system provides the key to new diagnostic tools and personalized medicine

FT-IR spectroscopy to show alterations in molecular composition of EV subpopulations from melanoma cell lines in different malignancy

Evaluation of exosome proteins by on-bead flow cytometry

Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy